content

DCPrime and apceth Biopharma GmbH Announce Manufacturing Partnership

DCPrime BV, a clinical stage company developing dendritic cell vaccines to treat cancer, and apceth Biopharma GmbH, an established contract manufacturing organization in the...

Nanobiotix Completes Patient Inclusion for Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma

NANOBIOTIX , a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, announced that it has completed patient inclusion for the...

New Unrivalled Capabilities Take GC-MS to the Next Level of Performance

Updated with new capabilities in high resolution accurate mass (HRAM) GC-MS, the Thermo Scientific Orbitrap GC-MS systems now give users across metabolomics, food safety,...

Nativisโ€™ platform aims to transform disease treatment on a global scale โ€“ โ€œa symphony of curesโ€

In late 2015, I was approached by the board of Nativis, Inc.to take on the leadership of the company, by then a 13-year-old โ€œstartup.โ€ I...

Medley Genomics and Transformative AI Selected as Winners in the 2017 Pistoia Alliance Presidentโ€™s Startup Challenge

The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, today announced the winners...

The Netherlands Cancer Institute Awarded Funding to Apply Molecular Imaging Technology to Prostate Cancer Surgery

The Netherlands Cancer Institute (NKI) announced that it has received funding from the Dutch Cancer Society (KWF Kankerbestrijding) to test whether a novel molecular...

ANTABIO Raises โ‚ฌ 7.3M Series A Financing to Develop Novel Treatments against Drug-Resistant Gram-Negative Infections

Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs, announced today the completion of a โ‚ฌ7.3M series. ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read